Episode

What are some potential risks of GLP-1 weight-loss drugs?

Podcast
ABC News Top Stories
Published
Jul 25, 2026
Duration seconds
179
Processing state
not_requested
Canonical source
https://www.abc.net.au/listen/programs/abc-news-top-stories/naus_glp1risksjaod_2507/106958374
Audio
https://mediacore-live-production.akamaized.net/audio/02/mr/Z/76.mp3
JSON
/v1/public/podcasts/abc-news-top-stories-6001594/episodes/what-are-some-potential-risks-of-glp-1-weight-loss-drugs
Markdown
/podcast/abc-news-top-stories-6001594/what-are-some-potential-risks-of-glp-1-weight-loss-drugs.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/abc-news-top-stories-6001594/episodes/what-are-some-potential-risks-of-glp-1-weight-loss-drugs/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/abc-news-top-stories-6001594/what-are-some-potential-risks-of-glp-1-weight-loss-drugs.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

The rise of GLP-1 medications such as Ozempic, Wegovy and Mounjaro has transformed the treatment of obesity and type 2 diabetes. But as their use rapidly increases, a growing list of potential risks are emerging.So how do GLP-1 drugs work? And what are the potential risks and benefits?